全部

1·Hodgkin lymphoma is not characterized by an increased WBC count.

霍奇金淋巴瘤中白细胞计数升高并不是其特征。

2·Epratuzumab and 90Y Epratuzumab for B cell non-Hodgkin lymphoma.

依帕珠单抗和钇-90标记的依帕珠单抗，用于B细胞非霍奇金淋巴瘤。

3·Radiotherapy may also be used in some cases of Non Hodgkin lymphoma.

放射治疗也可用于在某些情况下，非霍奇金淋巴瘤。

4·Treatment for Hodgkin lymphoma is usually given over a period of 6 8 months.

治疗霍奇金淋巴瘤通常是由于在过去一段六8个月。

5·Objective To investigate an effective therapy for gastrointestinal non - Hodgkin lymphoma (NHL).

目的探讨胃肠道非霍奇金淋巴瘤(NHL)的治疗方法。

6·Lymphomas, including Hodgkin lymphoma, result from an acquired injury to the DNA of a lymphocyte.

淋巴瘤，包括霍奇金淋巴瘤，是一个淋巴细胞的DNA获得性损伤造成的。

7·Lymphoma with signet ring cell features (LSF) is a rare morphologic variant of non-Hodgkin lymphoma.

印戒细胞型淋巴瘤(LSF)是非霍奇金淋巴瘤的一种罕见的形态变异。

8·Objective To research X-ray and CT findings and diagnosis of primary non-Hodgkin lymphoma of the bone.

目的探讨骨原发性非何杰金氏淋巴瘤的X线与CT表现及诊断要点。

9·Purpose: To study the salvage treatment of recurrent intermediate-high grade non Hodgkin lymphoma (NHL).

目的：研究复发性中高度非霍奇金淋巴瘤的解救治疗。

10·Non-Hodgkin lymphoma is deadlier than Hodgkin lymphoma, and is expected to kill more than 20, 000 people in 2010.

非霍奇金淋巴瘤的死亡率比霍奇金淋巴瘤高，预测2010年美国死于该病症的人数将超过20 000。